Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06969261 · ClinicalTrials.gov registry record · NA

Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT

A NA study of Opioid Use Disorder and Perinatal Opioid Use Disorder, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06969261 is a NA study of Opioid Use Disorder and Perinatal Opioid Use Disorder that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06969261, a NA study of Opioid Use Disorder and Perinatal Opioid Use Disorder, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurately to user generated input. The investigative team, in collaboration with the Penn Mixed Methods Research Lab (MMRL) and Penn's Way 2 Health Team, will use intervention mapping guided by the Consolidated Framework for Implementation Science. The investigators will conduct a needs assessment, assemble an advisory board, engage in pretesting to ensure safety and refine content, and pilot test the resultant adapted Penny COPILOT in a sample of 20 perinatal women with OUD to evaluate acceptability, feasibility, and patient satisfaction. The goal is to develop and refine an acceptable, feasible, and satisfactory supportive texting chatbot to promote patient engagement in perinatal and OUD care and decrease perceived loneliness.

Interventions

  • BEHAVIORAL Penny COPILOT

Study Locations (2)

Pennsylvania

  • Hospital of the University of Pennsylvania (HUP) - Philadelphia
  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-01-01
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT06969261

The ClinicalTrials.gov registry entry for NCT06969261 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Penny COPILOT is the first listed.

NCT06969261 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06969261 about?

NCT06969261 is a clinical study titled "Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT". To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILO...

What is the current status of trial NCT06969261?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-01-01. Estimated completion is 2026-06-30.

What conditions does trial NCT06969261 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Perinatal Opioid Use Disorder.

What interventions are being tested in trial NCT06969261?

The interventions under investigation include: Penny COPILOT (BEHAVIORAL).

Who is sponsoring clinical trial NCT06969261?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06969261 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.